Home › Head and Neck Cancer › Tennessee › Nashville
Head and Neck Cancer clinical trials in Nashville, TN
21 studies for Head and Neck Cancer are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- Sarah Cannon Research Institute, Nashville
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
RecruitingPhase 2/3
- Site#0126, Nashville
- Site #0116, Nashville
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
- SCRI Oncology Partners, Nashville
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RecruitingPhase 1
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
DESTINY-PANTUMOUR04
RecruitingObservational study
- Research Site, Nashville
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
RecruitingPhase 1
- Sarah Cannon and HCA Research Institute, Nashville
Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
Recruiting
- Barbara Murphy, Nashville
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
RecruitingPhase 1
- Vanderbilt University Medical Center, Nashville
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Sarah Cannon Research Institute, Nashville
Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
RecruitingPhase 1
- Vanderbilt University Medical Center, Nashville
Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema
Recruiting
- Vanderbilt University Medical Center, Nashville
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
- GSK Investigational Site, Nashville
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Recruiting
- Vanderbilt University Medical Center, Nashville
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- Sarah Cannon Research Institute, Nashville
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
- Vanderbilt-Ingram Cancer Center, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Nashville
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
RecruitingObservational studyHealthy volunteers welcome
- Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville
- Vanderbilt-Ingram Cancer Center at Franklin, Nashville
- Veterans Affairs Medical Center - Nashville, Nashville
- and 1 more
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RecruitingPhase 1/2
- Tennessee Oncology, Nashville
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RecruitingPhase 1
- Vanderbilt University Medical Center, Nashville
Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer
RecruitingPhase 1/2
- Vanderbilt-Ingram Cancer Center, Nashville
About Head and Neck Cancer
Head and neck cancer includes cancers of the mouth, nose, sinuses, salivary glands, throat, and lymph nodes. Read the different symptoms of each type.
More about Head and Neck Cancer on MedlinePlus
Head and Neck Cancer trials in other cities
- Houston, TX30 studies
- Boston, MA22 studies
- New York City, NY21 studies
- St. Louis, MO15 studies
- Dallas, TX12 studies
- Pittsburgh, PA11 studies
- Los Angeles, CA10 studies
- San Antonio, TX10 studies
- Baltimore, MD10 studies
- Washington, DC10 studies
- Durham, NC10 studies
- Chicago, IL10 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.